DIC is seen in which type of AML?
## **Core Concept**
Disseminated Intravascular Coagulation (DIC) is a serious disorder in which the proteins responsible for blood clotting become overactive, leading to widespread clot formation and bleeding. In the context of Acute Myeloid Leukemia (AML), certain subtypes are more commonly associated with DIC due to the release of pro-coagulant substances by the leukemic cells.
## **Why the Correct Answer is Right**
The correct answer, Acute Promyelocytic Leukemia (APL) or AML-M3, is strongly associated with DIC. APL is characterized by the accumulation of promyelocytes in the bone marrow and peripheral blood. These cells release granules that contain pro-coagulant factors, such as tissue factor, which initiates the coagulation cascade, leading to DIC. The high risk of DIC in APL is a well-established clinical feature, making it a critical consideration in the management of these patients.
## **Why Each Wrong Option is Incorrect**
- **Option A:** Other subtypes of AML, such as AML-M1 (myeloblastic leukemia with minimal maturation) or AML-M2 (myeloblastic leukemia with maturation), are not as strongly associated with DIC as APL. While coagulopathy can occur in these subtypes, it is less common and not as characteristic as in APL.
- **Option B:** Similarly, AML-M4 (myelomonocytic leukemia) and AML-M5 (monocytic leukemia) have different clinical features and are less commonly associated with DIC. These subtypes may have other specific complications, such as extramedullary disease in AML-M5.
- **Option D:** This option might refer to other less common subtypes of AML or mixed lineage leukemias, which are not typically characterized by a high risk of DIC as seen in APL.
## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that the presence of DIC in a patient with AML is highly suggestive of APL (AML-M3). Early recognition of APL and prompt initiation of treatment, including all-trans retinoic acid (ATRA) and chemotherapy, can significantly improve outcomes and reduce the risk of fatal bleeding complications. APL is a medical emergency, and its diagnosis should prompt immediate action.
## **Correct Answer:** . **Acute Promyelocytic Leukemia (AML-M3)**